Kevin A. Scott

1.7k total citations · 2 hit papers
15 papers, 1.3k citations indexed

About

Kevin A. Scott is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Kevin A. Scott has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 3 papers in Infectious Diseases. Recurrent topics in Kevin A. Scott's work include Chemical Synthesis and Analysis (4 papers), Antifungal resistance and susceptibility (3 papers) and Synthesis and biological activity (2 papers). Kevin A. Scott is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Antifungal resistance and susceptibility (3 papers) and Synthesis and biological activity (2 papers). Kevin A. Scott collaborates with scholars based in United States, Denmark and China. Kevin A. Scott's co-authors include Jón T. Njardarson, Philip B. Cox, H. Ralph Rawls, Spencer W. Redding, José L. López-Ribot, Nathalie Ropek, Bruno Melillo, Ekaterina V. Vinogradova, Benjamin F. Cravatt and Stuart L. Schreiber and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Kevin A. Scott

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of US FDA-Approved Drugs Containing Sulfur Atoms

2018 841 citations Kevin A. Scott, Jón T. Njardarson Topics in Current Chemistry profile →
Phenols in Pharmaceuticals: Analysis of a Recurring Motif

2022 133 citations Kevin A. Scott, Philip B. Cox et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Kevin A. Scott

Since Specialization

Citations

This map shows the geographic impact of Kevin A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Scott more than expected).

Fields of papers citing papers by Kevin A. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Scott. The network helps show where Kevin A. Scott may publish in the future.

Co-authorship network of co-authors of Kevin A. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Scott. A scholar is included among the top collaborators of Kevin A. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Scott. Kevin A. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Covalent targeting of splicing in T cells 2024 ·Cell chemical biology ·Kevin A. Scott, Hiroyuki Kojima, Nathalie Ropek, (unknown), (unknown), Simon J. Hogg, (unknown), (unknown), Xiaoyu Zhang, Jahan Rahman, Bruno Melillo, Benjamin F. Cravatt, Jiankun Lyu, Omar Abdel‐Wahab, Ekaterina V. Vinogradova	5
2	Protein State‐Dependent Chemical Biology 2023 ·Israel Journal of Chemistry ·Kevin A. Scott, (unknown), (unknown), Bryan Ngo, Ekaterina V. Vinogradova	2
3	Minimalistic graphical presentation approach for total syntheses 2022 ·Tetrahedron ·Kevin A. Scott, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael D. Delost, Jón T. Njardarson	0
4	Phenols in Pharmaceuticals: Analysis of a Recurring Motif breakdown → 2022 ·Journal of Medicinal Chemistry ·Kevin A. Scott, Philip B. Cox, Jón T. Njardarson	133
5	Stereochemical diversity as a source of discovery in chemical biology 2022 ·SHILAP Revista de lepidopterología ·Kevin A. Scott, Nathalie Ropek, Bruno Melillo, Stuart L. Schreiber, Benjamin F. Cravatt, Ekaterina V. Vinogradova	44
6	Dienolate Annulation Approach for Assembly of Densely Substituted Aromatic Architectures 2021 ·The Journal of Organic Chemistry ·Kevin A. Scott, (unknown), (unknown), Michael D. Delost, Pradipta Das, Jón T. Njardarson	5
7	Lessons in Stereochemistry: Resolution, Synthesis, and Characterization of Chiral Compounds 2020 ·Journal of Chemical Education ·Kevin A. Scott, (unknown), William G. Benson, Robin Polt	1
8	A Structural Analysis of the FDA Green Book-Approved Veterinary Drugs and Roles in Human Medicine 2020 ·Journal of Medicinal Chemistry ·Kevin A. Scott, (unknown), Philip B. Cox, (unknown), (unknown), (unknown), (unknown), Jón T. Njardarson	34
9	Chemistry Departments Should Facilitate Graduate-Level Second-Language Writing Instruction 2020 ·Journal of Chemical Education ·(unknown), Kevin A. Scott	3
10	Analysis of US FDA-Approved Drugs Containing Sulfur Atoms breakdown → 2018 ·Topics in Current Chemistry ·Kevin A. Scott, Jón T. Njardarson	841
11	New Class of Anion-Accelerated Amino-Cope Rearrangements as Gateway to Diverse Chiral Structures 2017 ·Journal of the American Chemical Society ·(unknown), Pradipta Das, (unknown), Kevin A. Scott, (unknown), K. N. Houk, Jón T. Njardarson	21
12	Potent Antifungal Synergy of Phthalazinone and Isoquinolones with Azoles Against Candida albicans 2017 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Kevin A. Scott, Nathan J. Oldenhuis, Haoping Liu, David L. Van Vranken	24
13	Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans 2015 ·ChemMedChem ·(unknown), Kevin A. Scott, (unknown), (unknown), Shelley Lane, Haoping Liu, David L. Van Vranken	15
14	Subcellular Protein Localization by Using a Genetically Encoded Fluorescent Amino Acid 2011 ·ChemBioChem ·Godefroid Charbon, Eric M. Brustad, Kevin A. Scott, Jiangyun Wang, Anders Løbner‐Olesen, Peter G. Schultz, Christine Jacobs‐Wagner, Eli Chapman	43
15	Inhibition of Candida albicans biofilm formation on denture material 2009 ·Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology ·Spencer W. Redding, (unknown), H. Ralph Rawls, (unknown), Kevin A. Scott, José L. López-Ribot	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact